Submissions from 2021
Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors, Yazmin Odia and Bruno Bastos
Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies, Tugce Kutuk
Mitigating the risk of transfusion-transmitted bacterial infections in hematology oncology patients, Harold Alvarez and Guenther Koehne
Neurological complications of Head and Neck cancer, Manmeet Ahluwalia, Shreya Saxena, and Karanvir Singh
OC-0415 Long-term outcomes of MR-guided SABR & on-table adaptive replanning for unresectable pancreas cancer, Michael Chuong, Kathryn Mittauer, Tino Romaguera, Diane Alvarez, Rupesh Kotecha, Matthew Hall, Adeel Kaiser, John Bryant, James McCulloch, Antonio Ucar, Horacio Asbun, Govindarajan Narayanan, Alonso Gutierrez, Muni Rubens, and Robert Herrera
Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes, Guenther Koehne
OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Minesh Mehta, Michael McDermott, manmeet Ahluwalia, and Rupesh Kotecha
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-Type TP53, Guilherme Rabinowits
Prevalence and Inpatient Hospital Outcomes of Malignancy-Related Ascites in the United States, Muni Rubens, Anshul Saxena, Chintan Bhatt, Sankalp Das, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Rupesh Kotecha, and Minesh Mehta
Proton Therapy Specific Salivary Gland Volume Changes After Head and Neck Radiotherapy, Tugce Kutuk, Jessika Contreras, Adeel Kaiser, and Noah Kalman
RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis, Rupesh Kotecha, Raees Tonse, Zuanel Diaz, Martin Tom, Matthew Hall, Minesh Mehta, Vitaly Siomin, and Manmeet Ahluwalia
Shoulder Dysfunction in Breast Cancer, Adrian Cristian
Stereotactic Radiosurgery and Immunotherapy, Rupesh Kotecha, Raees Tonse, and Manmeet Ahluwalia
Stereotactic Radiosurgery/Radiotherapy with Particle Therapy, Raees Tonse, Andrew Wroe, Rupesh Kotecha, and Minesh Mehta
Submandibular Gland Transfer for the Prevention of Radiation Induced Xerostomia in Head and Neck Cancer – Dosimetric Impact with Intensity Modulated Radiotherapy, Tugce Kutuk, Nicole McAllister, Adeel Kaiser, Jessika Contreras, and Noah Kalman
Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03, Manmeet Ahluwalia
Systemic Therapy and Radiation Therapy in Lung Cancer, Raees Tonse, Martin Tom, and Rupesh Kotecha
Systemic Therapy for the Treatment of Breast Cancer, Ana Cristina Sandoval Leon
Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference, Riccardo Lencioni
Understanding Early Palliative Care Interventions for Patients With Hematologic Malignancies Undergoing Bone Marrow Transplantation, Corey Suthumphong and Marco Ruiz Andia
Using CBCT to Monitor Treatment Dose Delivery Accuracy in Head and Neck Proton Radiotherapy, Pouya Sabouri
Utilizing Radiation Dose Maps to Predict Local Failure following Stereotactic Radiation of Brain Metastases, Tugce Kutuk
Submissions from 2020
Radiotherapy Innovations to Optimize Brain Metastases Control, Minesh Mehta
GRIP STRENGTH CHANGES IN BONE MARROW TRANSPLANT PATIENTS, Adrian Cristian and Marco Ruiz Andia